Document is current
Any future updates will be listed below
-
Authors
Bracaglia, Claudia
Minoia, Francesca
Vastert, Sebastiaan J.
Kessel, Christoph
Dagna, Lorenzo
Ravelli, Angelo
De Benedetti, Fabrizio
-
Funding
Funding for this research was provided by:
Sobi
- License Information
-
More Information
Article History
Received: 3 March 2025
Accepted: 3 April 2025
First Online: 23 April 2025
Declarations
:
: Not applicable.
: Not applicable.
: CB: Consultant for Sobi and Novartis, and Speaker for GSK. FM: Consultant for Sobi and Novartis. SJV: Speaker for Sobi and Novartis, and unrestricted research grant from Sobi in a public private grant application. CK: Consultant/Speaker for Sobi and Novartis, and research support from Novartis. LD: Consultant for and honoraria from AbbVie, Alfasigma, Amgen, AstraZeneca, Biogen, Bristol Myers Squibb, Celgene, Eli Lilly, Galapagos, GSK, Janssen, Kiniksa Pharmaceuticals, Merk Sharp & Dohme, Mundipharma Pharmaceuticals, Novartis, Pfizer, Roche, Sanofi-Genzyme, Sobi, and Vifor. AR: Consultant for Galapagos and Novartis, and Speaker for Alexion, Sobi, and Novartis. FDB: Consultant for Sobi, Novartis, Sanofi, Elixiron, Apollo, and Kiniksa Pharmaceuticals, and Speaker for Sobi, Sanofi, Novartis, and Fresenius Kabi. Angelo Ravelli is Co-Editor-in-Chief of Pediatric Rheumatology, Christoph Kessel is Senior Editor of the journal, and Claudia Bracaglia, Francesca Minoia, Fabrizio de Benedetti, and Baas Vastert are Members of the Editorial Board of the journal. The peer review of this paper was therefore overseen by an independent member of the editorial board and the submission was subject to the same review process as applied to any other manuscript.
